Table 3 Risk Factors for development of rifampicin-resistant TB
From: Experience on the first national anti-TB drug resistance survey (DRS) in Timor-Leste
Variable | Level | Total TB caes | RR-TB cases | Odds raion (95% CI) | p-value |
|---|---|---|---|---|---|
Treatment history | New | 844 | 5 | 0.11 | |
Previously treated | 73 | 2 | 4.7 (0.7–22.4) | ||
Gender | Male | 524 | 4 | 0.96 | |
Female | 393 | 3 | 1.0 (0.2–4.8) | ||
HIV statusa | Negative | 904 | 7 | NA | |
Positive | 12 | 0 | NA | ||
Age | 15–24 | 223 | 1 | 0.99 | |
0–14 | 19 | 0 | NA | ||
25–34 | 198 | 2 | 4.5 (0.2–43.4) | ||
35–44 | 118 | 1 | 1.8 (0.1–47.1) | ||
45–54 | 125 | 1 | 1.4 (0.1–36.3) | ||
55–64 | 113 | 1 | 2.0 (0.1–50.1) | ||
65 + | 121 | 1 | 1.6 (0.1–41.4) | ||
Municipality | Other municipalities | 592 | 2 | 0.06 | |
Dili capital | 325 | 5 | 4.5 (1.0–31.7) |